UCPVax
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for UCPVax, covering 2024-12-20 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma [Phase 2]